Coeliac Disease and Mast Cells.

Barbara Frossi, Marco De Carli, Antonino Calabrò

Journal: International journal of molecular sciences 2020;20(14):3400

PMID: 31373285

Abstract

Over the last decades, there has been an impressive progress in our understanding of coeliac disease pathogenesis and it has become clear that the disorder is the final result of complex interactions of environmental, genetic, and immunological factors. Coeliac disease is now considered a prototype of T-cell-mediated disease characterized by loss of tolerance to dietary gluten and the targeted killing of enterocytes by T-cell receptor αβ intraepithelial lymphocytes. Accumulating evidence, however, indicates that the induction of a gluten-specific T helper-1 response must be preceded by the activation of the innate immune system. Mast cells are key players of the innate immune response and contribute to the pathogenesis of a multitude of diseases. Here, we review the results of studies aimed at investigating the role of mast cells in the pathogenesis of coeliac disease, showing that these cells increase in number during the progression of the disease and contribute to define a pro-inflammatory microenvironment.

Address: Department of Medical and Biological Science, University of Udine, 33100 Udine, Italy.; Second Unit of Internal Medicine, University Hospital of Udine, 33100 Udine, Italy. [email protected].; Department of Experimental and Clinical Biomedical Sciences "Mario Serio", University Hospital of Florence, 50134 Florence, Italy.; Tuscany Referral Center for Adult Coeliac Disease, AOU Careggi, 50134 Florence, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.